Kodiak Sciences Inc.(KOD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

KOD Kodiak Sciences Inc.

Trading 01-21 10:12:17 EST

27.49

+0.85

+3.19%

High27.99	Low26.58	Vol69.23K
Open26.58	D1 Closing26.64	Amplitude5.29%
Mkt Cap1.68B	Tradable Cap1.01B	Total Shares61.05M
T/O1.89M	T/O Rate0.19%	Tradable Shares36.88M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"KOD","market":"US","secType":"STK","nameCN":"Kodiak Sciences Inc.","latestPrice":27.49,"timestamp":1769008300373,"preClose":26.64,"halted":0,"volume":69232,"delay":0,"changeRate":0.031906906906906826,"floatShares":36879500,"shares":61048400,"eps":-4.119388,"marketStatus":"Trading","change":0.85,"latestTime":"01-21 10:12:17 EST","open":26.58,"high":27.99,"low":26.58,"amount":1889870.974032,"amplitude":0.052928,"askPrice":27.63,"askSize":200,"bidPrice":27.49,"bidSize":108,"shortable":3,"etf":0,"ttmEps":-4.119388,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1769029200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1538625600000,"exchange":"NASDAQ","adjPreClose":26.64,"preHourTrading":{"tag":"盘前","latestPrice":26.3,"preClose":26.64,"latestTime":"09:16 EST","volume":107,"amount":2853.650196,"timestamp":1769004996383,"change":-0.34,"changeRate":-0.012763,"amplitude":0.018769},"postHourTrading":{"tag":"盘后","latestPrice":26.66,"preClose":26.64,"latestTime":"19:50 EST","volume":7790,"amount":207584.49,"timestamp":1768956620172,"change":0.02,"changeRate":0.000751,"amplitude":0.000751},"volumeRatio":0.831846,"impliedVol":1.1396,"impliedVolPercentile":0.6255},"requestUrl":"/m/hq/s/KOD/tweets","defaultTab":"tweets","newsList":[{"id":"2602443305","title":"Canaccord Genuity Sticks to Their Buy Rating for Kodal Minerals (KOD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2602443305","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602443305?lang=en_us&edition=fundamental","pubTime":"2026-01-10 02:58","pubTimestamp":1767985095,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Alexander Bedwany from Canaccord Genuity reiterated a Buy rating on Kodal Minerals, with a price target of p1.00. T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-sticks-to-their-buy-rating-for-kodal-minerals-kod-blurbs-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-sticks-to-their-buy-rating-for-kodal-minerals-kod-blurbs-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KOD","MTX"],"gpt_icon":0},{"id":"2601866633","title":"Kodiak Sciences Initiated at Buy by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2601866633","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601866633?lang=en_us&edition=fundamental","pubTime":"2026-01-08 04:31","pubTimestamp":1767817860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KOD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 07, 2026 15:31 ET (20:31 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD","BK4505","BK4139"],"gpt_icon":0},{"id":"2593464060","title":"U.S. RESEARCH ROUNDUP-APi Group, Elf Beauty, Tesla","url":"https://stock-news.laohu8.com/highlight/detail?id=2593464060","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593464060?lang=en_us&edition=fundamental","pubTime":"2025-12-23 15:05","pubTimestamp":1766473503,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-APi Group, Elf Beauty, Tesla Dec 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including APi Group, Elf","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nL4N3XT0BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EL","CNO","LW","HEI","GEMI","CENX","IE00BJTD4N35.SGD","LINE","CCL","CYTK","MNST","FCEL","FCX","SCHW","LU0708994859.HKD","LU2237957811.SGD","LU1668664300.SGD","META","FLUT","LNC","ICE","XYZ","KMI","CBOE","ABX","AM","LU0823421333.USD","LU0795875086.SGD","MANH","MKTX","AJG","CME","SATS","LU2552382058.USD","AA","LU2552382132.HKD","ARWR","BMRN","KBH","MET","KOD","APG","ABL","ELF","LPLA","LU0053671581.USD","BRO","INTA","BTSG","LU0208291251.USD","AME"],"gpt_icon":1},{"id":"2593900120","title":"Kodiak Sciences (KOD): Assessing Valuation After Its $160 Million Capital Raise for Late-Stage Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2593900120","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593900120?lang=en_us&edition=fundamental","pubTime":"2025-12-21 22:12","pubTimestamp":1766326347,"startTime":"0","endTime":"0","summary":"Kodiak Sciences (KOD) just wrapped up a sizable follow on stock offering, raising roughly $160 million to help fund its late stage eye disease drug programs and shore up its balance sheet.\nSee our latest analysis for Kodiak Sciences.\nThat capital raise lands after a huge run, with Kodiak’s 90 day share price return of 73.22 percent and year to date share price return of 201.62 percent, signalling strong, speculative momentum despite a bruising 5 year total shareholder return of negative 83.12...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kod/kodiak-sciences/news/kodiak-sciences-kod-assessing-valuation-after-its-160-millio","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kod/kodiak-sciences/news/kodiak-sciences-kod-assessing-valuation-after-its-160-millio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SSI","BK4139","BK4505","KOD"],"gpt_icon":0},{"id":"2592197441","title":"Felix J. Baker, Director, Reports Acquisition of Kodiak Sciences Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592197441","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592197441?lang=en_us&edition=fundamental","pubTime":"2025-12-20 05:07","pubTimestamp":1766178431,"startTime":"0","endTime":"0","summary":"Baker Bros. Advisors LP, along with other reporting beneficial owners, has reported the acquisition of common shares of Kodiak Sciences Inc. The transaction was disclosed in a recent SEC filing. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kodiak Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 19, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL9HqzJK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Felix J. Baker, Director, Reports Acquisition of Kodiak Sciences Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","KOD"],"gpt_icon":0},{"id":"2592913067","title":"BUZZ-U.S. STOCKS ON THE MOVE-Jabil, Texas Pacific Land, Texas Roadhouse","url":"https://stock-news.laohu8.com/highlight/detail?id=2592913067","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592913067?lang=en_us&edition=fundamental","pubTime":"2025-12-17 22:14","pubTimestamp":1765980847,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Jabil, Texas Pacific Land, Texas RoadhouseEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call new","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nL6N3XN0N8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HL","LU2750360641.GBP","USAW.SI","AVTR","FDX","CVS","KOD","UDMY","VOR","WSBC","NWBI","IMNM","GIS","VERU","MCK","PSKY","SCCO","COR","AIR","NUE","DHR","ALB","APOG","ABM","LU2063271972.USD","FISI","WAT","NEM","TXRH","CDE","XENE","JBL","KYMR","HUT","FCF","CYTK","STLD","PANW","NEO","TPL","VSCO","FTNT","FCX","COUR","TE"],"gpt_icon":1},{"id":"2592918206","title":"BUZZ-Kodiak Sciences dips after boosted $160 mln equity raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2592918206","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592918206?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:39","pubTimestamp":1765978745,"startTime":"0","endTime":"0","summary":"** Eye-drug developer Kodiak Sciences' KOD.O shares down 0.6% before the bell at $23.98 after $160 mln follow-on priced. biotech late Tues said it sold ~7 mln shares at $23, a 4.7% discount to last sale. ** KOD shares closed up nearly 5% on Tues after co late Mon commenced 6 mln share offering. ** Co, which has ~53 mln shares outstanding, plans to use net proceeds for working capital and general corp purposes, per the prospectus. ** JP Morgan, Jefferies, Evercore and UBS are joint bookrunners. ** Through Tues close, KOD shares surged nearly seven-fold over the past six months, putting them up ~143% YTD. ** Avg rating among 8 analysts is \"buy\" and median PT is $24, per LSEG data","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nL6N3XN0ZW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2756315664.SGD","LU0265550359.USD","LU1244550494.USD","BK4505","IE00BLSP4239.USD","LU2106854487.HKD","LU0211326839.USD","LU1363072403.SGD","LU1366192091.USD","BK4207","LU2213496289.HKD","SG9999002232.USD","LU0048584097.USD","EVR","LU1668664300.SGD","LU2505996509.AUD","LU2237443895.HKD","LU2237443622.USD","LU2552382215.SGD","IE00BJTD4V19.USD","LU0208291251.USD","LU0211326755.USD","IE00BN8TJ469.HKD","LU0820562030.AUD","LU1244550577.SGD","LU1280957306.USD","LU0820561818.USD","LU2552382058.USD","IE0034235303.USD","LU2023250330.USD","IE00B3S45H60.SGD","IE00B1XK9C88.USD","LU1032466523.USD","BK4516","LU2456880835.USD","BK4534","BK4550","KOD","IE00BWXC8680.SGD","IE00BDRTCR15.USD","LU2430703251.USD","LU0310799852.SGD","LU1720051108.HKD","LU2746668974.SGD","BK4504","LU2237443978.SGD","LU0211331839.USD","LU1116320901.HKD","LU1267930490.SGD","LU2505996681.GBP"],"gpt_icon":0},{"id":"2592998887","title":"Kodiak Sciences Prices $160 Million Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2592998887","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592998887?lang=en_us&edition=fundamental","pubTime":"2025-12-17 16:44","pubTimestamp":1765961086,"startTime":"0","endTime":"0","summary":"Kodiak Sciences  said late Tuesday it priced an upsized underwritten offering of nearly 7 million shares at $23 per share for gross proceeds of about $160 million.The offering, which was upsized from 6 million shares, is expected to close on Thursday, the company said.The company said it granted underwriters a 30-day option to buy up to an additional 1 million shares at offering price, minus discounts and commissions.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4505","KOD"],"gpt_icon":0},{"id":"2592497968","title":"BRIEF-Kodiak Sciences Prices Upsized Offering Of 7 Mln Shares At $23.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2592497968","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592497968?lang=en_us&edition=fundamental","pubTime":"2025-12-17 11:57","pubTimestamp":1765943872,"startTime":"0","endTime":"0","summary":"BRIEF-Kodiak Sciences Prices Upsized Offering Of 7 Mln Shares At $23.00Dec 16 (Reuters) - Kodiak Sciences Inc KOD.O:KODIAK SCIENCES ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING OF COMMON STOCKKODIAK S","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUABVPWQN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KOD","BK4505"],"gpt_icon":0},{"id":"2592460968","title":"Kodiak Sciences Announces Pricing of Upsized Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2592460968","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592460968?lang=en_us&edition=fundamental","pubTime":"2025-12-17 11:55","pubTimestamp":1765943744,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUABVPWQN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KOD","BK4505","BK4139"],"gpt_icon":0},{"id":"2591622148","title":"BUZZ-Kodiak Sciences drops after stock deal unveil","url":"https://stock-news.laohu8.com/highlight/detail?id=2591622148","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591622148?lang=en_us&edition=fundamental","pubTime":"2025-12-16 06:00","pubTimestamp":1765836045,"startTime":"0","endTime":"0","summary":"BUZZ-Kodiak Sciences drops after stock deal unveil** Shares of eye-drug developer Kodiak Sciences KOD.O down 4.4% in extended trading to $22 as it looks to raise equity** Palo Alto, California-based precommercial biotech commences 6 mln share offering** JP Morgan, Jefferies, Evercore and UBS are joint bookrunners** KOD shares fell for 5th-straight session on Mon, finishing down 3.3% at $23.02. But the stock has soared more than six-fold over the past six months** With ~53 mln shares outstanding, co has $1.2 bln market cap** Of 8 analysts covering KOD, recommendation breakdown is 5 \"strong buy\" or \"buy\", 2 \"hold\" and 1\"sell\"; median PT is $24, current LSEG data reflects","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nL6N3XL15U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","LU2552382215.SGD","LU0640476718.USD","LU2746668461.USD","LU1119994496.HKD","LU0964807845.USD","LU2023250504.SGD","LU0215105999.USD","IE00BJTD4V19.USD","LU2023250330.USD","KOD","LU2462157665.USD","LU0267386448.USD","LU0203347892.USD","IE00B3S45H60.SGD","LU2106854487.HKD","LU0345769631.USD","LU1162221912.USD","LU0345770993.USD","BK4505","LU2505996509.AUD","LU1366192091.USD","LU0310799852.SGD","IE0034235295.USD","LU1145028129.USD","LU1244550221.USD","LU1280957306.USD","LU0265550946.USD","LU2746668974.SGD","LU2756315664.SGD","LU0976567544.SGD","BK4516","LU2552382058.USD","LU0820562030.AUD","LU0971096721.USD","LU2054465674.USD","LU1032466523.USD","LU1267930490.SGD","LU2237443895.HKD","LU0787776722.HKD","LU2417539215.USD","LU0417517546.SGD","IE00BLSP4452.SGD","LU0882574139.USD","EVR","LU2592432038.USD","LU0208291251.USD","LU1668664300.SGD","LU1548497426.USD","BK4534"],"gpt_icon":0},{"id":"2591762487","title":"Kodiak Sciences Launches Share Offering; Stock Falls After Hours","url":"https://stock-news.laohu8.com/highlight/detail?id=2591762487","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591762487?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:13","pubTimestamp":1765833207,"startTime":"0","endTime":"0","summary":"Kodiak Sciences (KOD) launched a public offering of 6 million common shares.Underwriters were granted a 30-day overallotment option to buy up to an additional 900,000 shares at the offering price, Kodiak said Monday in a statement.The company's stock fell 4.4% in after-hours trading.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4505","KOD"],"gpt_icon":0},{"id":"2591762127","title":"BRIEF-Kodiak Sciences Announces Proposed Public Offering Of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2591762127","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591762127?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:03","pubTimestamp":1765832632,"startTime":"0","endTime":"0","summary":"BRIEF-Kodiak Sciences Announces Proposed Public Offering Of Common StockDec 15 (Reuters) - Kodiak Sciences Inc KOD.O:KODIAK SCIENCES ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCKKODIAK SCIENCES I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nTUAB47NGK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","KOD"],"gpt_icon":0},{"id":"2584974193","title":"Kodiak Sciences (KOD): Assessing Valuation Following Q3 Losses and Advancing Pipeline Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2584974193","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584974193?lang=en_us&edition=fundamental","pubTime":"2025-11-20 04:13","pubTimestamp":1763583232,"startTime":"0","endTime":"0","summary":"Kodiak Sciences (KOD) shares were in focus this week after the company reported a larger third quarter net loss. This reflects rising research and development and manufacturing expenses tied to its advancing clinical pipeline.\nSee our latest analysis for Kodiak Sciences.\nDespite Kodiak Sciences’ wider net loss making headlines, investors have shrugged off short-term volatility, with the 1-month share price return climbing 8.6% and the year-to-date gain reaching a remarkable 123%. Even more...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kod/kodiak-sciences/news/kodiak-sciences-kod-assessing-valuation-following-q3-losses","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kod/kodiak-sciences/news/kodiak-sciences-kod-assessing-valuation-following-q3-losses","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4505","BK4139","KOD"],"gpt_icon":0},{"id":"1131928204","title":"Stock Track | Kodiak Sciences Soars 5.02% as H.C. Wainwright Raises Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1131928204","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131928204?lang=en_us&edition=fundamental","pubTime":"2025-11-17 23:08","pubTimestamp":1763392110,"startTime":"0","endTime":"0","summary":"Shares of Kodiak Sciences Inc. (KOD) are soaring 5.02% in pre-market trading on Monday, following a series of analyst actions, most notably a price target increase from H.C. Wainwright. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["KOD"],"gpt_icon":0},{"id":"1142190917","title":"Stock Track | Kodiak Sciences Soars 5.02% as H.C. Wainwright Raises Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1142190917","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142190917?lang=en_us&edition=fundamental","pubTime":"2025-11-17 23:08","pubTimestamp":1763392106,"startTime":"0","endTime":"0","summary":"Shares of Kodiak Sciences Inc. (KOD) surged 5.02% in Monday's pre-market trading session following a notable price target upgrade from a prominent Wall Street analyst. The biotechnology company,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["KOD"],"gpt_icon":0},{"id":"1157657438","title":"Stock Track | Kodiak Sciences (KOD) Plummets 5.43% in Pre-Market Despite Mixed Analyst Actions","url":"https://stock-news.laohu8.com/highlight/detail?id=1157657438","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157657438?lang=en_us&edition=fundamental","pubTime":"2025-11-17 22:34","pubTimestamp":1763390097,"startTime":"0","endTime":"0","summary":"Shares of Kodiak Sciences Inc. (KOD) plummeted 5.43% in pre-market trading on Monday, despite receiving mixed analyst actions. The significant drop suggests that investors may be responding...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["KOD"],"gpt_icon":0},{"id":"1161503302","title":"Stock Track | Kodiak Sciences Plummets 5.43% Despite Analyst Price Target Hike and Neutral Ratings","url":"https://stock-news.laohu8.com/highlight/detail?id=1161503302","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161503302?lang=en_us&edition=fundamental","pubTime":"2025-11-17 22:34","pubTimestamp":1763390092,"startTime":"0","endTime":"0","summary":"Kodiak Sciences Inc. (KOD) experienced a sharp decline in the pre-market session on Monday, with its stock plummeting 5.43% despite receiving mixed signals from Wall Street analysts. The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["KOD"],"gpt_icon":0},{"id":"2584628859","title":"Kodiak Sciences Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2584628859","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584628859?lang=en_us&edition=fundamental","pubTime":"2025-11-17 20:03","pubTimestamp":1763380980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KOD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 17, 2025 07:03 ET (12:03 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","KOD"],"gpt_icon":0},{"id":"2584421586","title":"Kodiak Sciences Inc. : H.c. Wainwright Raises Target Price to $26 From $24","url":"https://stock-news.laohu8.com/highlight/detail?id=2584421586","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584421586?lang=en_us&edition=fundamental","pubTime":"2025-11-17 19:08","pubTimestamp":1763377737,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nAZN4QTUN6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4505","KOD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kodiak.com","stockEarnings":[{"period":"1week","weight":-0.0593},{"period":"1month","weight":0.0246},{"period":"3month","weight":0.4759},{"period":"6month","weight":2.2291},{"period":"1year","weight":2.7155},{"period":"ytd","weight":-0.0472}],"compareEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.0044},{"period":"3month","weight":0.0146},{"period":"6month","weight":0.068},{"period":"1year","weight":0.1339},{"period":"ytd","weight":-0.0064}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.059224},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.132442},{"month":3,"riseRate":0,"avgChangeRate":-0.148215},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.000503},{"month":5,"riseRate":0.571429,"avgChangeRate":0.076422},{"month":6,"riseRate":0.714286,"avgChangeRate":0.026986},{"month":7,"riseRate":0.571429,"avgChangeRate":0.078061},{"month":8,"riseRate":0.571429,"avgChangeRate":0.018756},{"month":9,"riseRate":0.714286,"avgChangeRate":0.127765},{"month":10,"riseRate":0.714286,"avgChangeRate":0.212883},{"month":11,"riseRate":0.75,"avgChangeRate":0.296496},{"month":12,"riseRate":0.625,"avgChangeRate":0.266402}],"exchange":"NASDAQ","name":"Kodiak Sciences Inc.","nameEN":"Kodiak Sciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kodiak Sciences Inc.(KOD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Kodiak Sciences Inc.(KOD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Kodiak Sciences Inc.,KOD,Kodiak Sciences Inc.股票,Kodiak Sciences Inc.股票老虎,Kodiak Sciences Inc.股票老虎国际,Kodiak Sciences Inc.行情,Kodiak Sciences Inc.股票行情,Kodiak Sciences Inc.股价,Kodiak Sciences Inc.股市,Kodiak Sciences Inc.股票价格,Kodiak Sciences Inc.股票交易,Kodiak Sciences Inc.股票购买,Kodiak Sciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kodiak Sciences Inc.(KOD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Kodiak Sciences Inc.(KOD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}